Medication for alzheimer's disease and associated fall hazard: A retrospective cohort study from the alzheimer's disease neuroimaging initiative

Drugs and Aging

Volumn 31, Issue 2, 2014, Pages 125-129

  Epstein, Noam U ^a,b   Guo, Rong ^c   Farlow, Martin R ^d   Singh, Jaswinder P ^b   Fisher, Morris ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CASE-CONTROL STUDIES; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; HUMANS; MEMANTINE; MILD COGNITIVE IMPAIRMENT; MULTIVARIATE ANALYSIS; NEUROIMAGING; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 84894097377     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-013-0143-3     Document Type: Article

References (17)

1. Buchner DM, Larson EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA. 1987;257(11):1492-5.
2. Epstein NU, Saykin AJ, Risacher SL, Gao S, Farlow MR, Alzheimer's Disease Neuroimaging Initiative. Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics. Drugs Aging. 2010;27(8):677-86.
3. Sterke CS, van Beeck EF, van der Velde N, Ziere G, Petrovic M, Looman CW, et al. New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol. 2012;52(6):947-55.
4. Assal F, Allali G, Kressig RW, Herrmann FR, Beauchet O. Galantamine improves gait performance in patients with Alzheimer's disease. J Am Geriatr Soc. 2008;56(5):946-7.
5. Montero-Odasso M, Wells J, Borrie M. Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls. J Am Geriatr Soc. 2009;57(2):359-60.
6. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dementia. 2011;7(3):270-9.
7. ADNI procedure manual. http://www.adni-info.org/Scientists/Pdfs/ adniproceduresmanual12.pdf. Accessed 23 Oct 2013.
8. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716-24.
9. Voisin T, Sourdet S, Cantet C, Andrieu S, Vellas B. Descriptive analysis of hospitalizations of patients with Alzheimer's disease: a two-year prospective study of 686 patients from the REAL.FR study. J Nutr Health Aging. 2009;13(10):890-2.
10. Tinetti ME. Factors associated with serious injury during falls by ambulatory nursing home residents. J Am Geriatr Soc. 1987;35(7):644-8.
11. Suttanon P, Hill KD, Said CM, Logiudice D, Lautenschlager NT, Dodd KJ. Balance and mobility dysfunction and falls risk in older people with mild to moderate Alzheimer disease. Am J Phys Med Rehabil. 2012;91(1):12-23.
12. Gallini A, Sommet A, Montastruc JL, French PharmacoVigilance Network. Does memantine induce bradycardia? A study in the French PharmacoVigilance Database. Pharmacoepidemiol Drug Saf. 2008;17(9):877-81.
13. Bordier P, Lanusse S, Garrigue S, Reynard C, Robert F, Gencel L, et al. Causes of syncope in patients with Alzheimer's disease treated with donepezil. Drugs Aging. 2005;22(8):687-94.
14. Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, et al. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology. 2001;57(3):481-8.
15. Farlow MR, Graham SM, Alva G. Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trials. Drug Saf. 2008;31(7):577-85.
16. Kim DH, Brown RT, Ding EL, Kiel DP, Berry SD. Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials. J Am Geriatr Soc. 2011;59(6):1019-31.
17. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 2006;(1):CD005593.